David A. Flick

1.0k total citations · 1 hit paper
10 papers, 930 citations indexed

About

David A. Flick is a scholar working on Molecular Biology, Immunology and Cellular and Molecular Neuroscience. According to data from OpenAlex, David A. Flick has authored 10 papers receiving a total of 930 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Immunology and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in David A. Flick's work include Immune Response and Inflammation (3 papers), Chemical Synthesis and Analysis (2 papers) and Antimicrobial Peptides and Activities (2 papers). David A. Flick is often cited by papers focused on Immune Response and Inflammation (3 papers), Chemical Synthesis and Analysis (2 papers) and Antimicrobial Peptides and Activities (2 papers). David A. Flick collaborates with scholars based in United States and Germany. David A. Flick's co-authors include George E. Gifford, Llewellyn H. Mason, Ronald B. Herberman, John R. Ortaldo, Shu‐Mei Liang, Bonnie J. Mathieson, Karl Kolter, Abdallah Badou, George B. Butler and Xing Ye and has published in prestigious journals such as Nature, JNCI Journal of the National Cancer Institute and Annals of the New York Academy of Sciences.

In The Last Decade

David A. Flick

10 papers receiving 894 citations

Hit Papers

Comparison of in vitro cell cytotoxic assays for tumor ne... 1984 2026 1998 2012 1984 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David A. Flick United States 7 435 258 109 109 72 10 930
Dennis W. McGee United States 19 334 0.8× 380 1.5× 121 1.1× 63 0.6× 84 1.2× 46 1.0k
Jon R. Schmidtke United States 16 719 1.7× 364 1.4× 107 1.0× 91 0.8× 34 0.5× 42 1.3k
M.L. Castellani Italy 19 456 1.0× 217 0.8× 174 1.6× 83 0.8× 57 0.8× 54 1.0k
Klaus Vosbeck Switzerland 14 245 0.6× 450 1.7× 98 0.9× 101 0.9× 69 1.0× 22 1.1k
Vinod Singh India 13 315 0.7× 245 0.9× 140 1.3× 120 1.1× 51 0.7× 43 984
Nieves Fernández Spain 20 454 1.0× 317 1.2× 98 0.9× 102 0.9× 63 0.9× 46 997
G. Loison France 12 546 1.3× 499 1.9× 133 1.2× 81 0.7× 40 0.6× 16 1.3k
M W Vermeulen United States 13 519 1.2× 299 1.2× 149 1.4× 284 2.6× 96 1.3× 19 1.1k
Liana Verinaud Brazil 21 362 0.8× 311 1.2× 84 0.8× 188 1.7× 72 1.0× 61 1.1k
SJ Klebanoff United States 13 550 1.3× 332 1.3× 76 0.7× 165 1.5× 49 0.7× 18 1.2k

Countries citing papers authored by David A. Flick

Since Specialization
Citations

This map shows the geographic impact of David A. Flick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Flick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Flick more than expected).

Fields of papers citing papers by David A. Flick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Flick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Flick. The network helps show where David A. Flick may publish in the future.

Co-authorship network of co-authors of David A. Flick

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Flick. A scholar is included among the top collaborators of David A. Flick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Flick. David A. Flick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Gifford, George E. & David A. Flick. (2007). Natural Production and Release of Tumour Necrosis Factor. Novartis Foundation symposium. 131. 3–20. 5 indexed citations
2.
Kolter, Karl & David A. Flick. (2000). Structure and Dry Binding Activity of Different Polymers, Including Kollidon® VA 64. Drug Development and Industrial Pharmacy. 26(11). 1159–1165. 22 indexed citations
3.
Gifford, George E. & David A. Flick. (1988). Tumour necrosis factor.. PubMed. 5(4). 104–7. 6 indexed citations
4.
Butler, George B., et al.. (1987). Synthesis and Characterization of Polyanionic Materials for Testing of Antitumor Activity. I-The 1:2 Cyclocopolymer of Citraconic Anhydride and Divinyl Ether. Journal of Bioactive and Compatible Polymers. 2(3). 206–221. 1 indexed citations
5.
Flick, David A., et al.. (1986). Pharmacokinetics of Murine Tumor Necrosis Factor. Immunopharmacology and Immunotoxicology. 8(1). 89–97. 46 indexed citations
6.
Ortaldo, John R., Llewellyn H. Mason, Bonnie J. Mathieson, et al.. (1986). Mediation of mouse natural cytotoxic activity by tumour necrosis factor. Nature. 321(6071). 700–702. 107 indexed citations
7.
Flick, David A. & George E. Gifford. (1986). Production of tumor necrosis factor in unprimed mice: Mechanism of endotoxin-mediated tumor necrosis. Immunobiology. 171(4-5). 320–328. 34 indexed citations
8.
Butler, George B., Xing Ye, George E. Gifford, & David A. Flick. (1985). Physical and Biological Properties of Cyclopolymers Related to DIVEMA (“Pyran Copolymer”). Annals of the New York Academy of Sciences. 446(1). 149–159. 5 indexed citations
9.
Gifford, George E., et al.. (1984). Production of a Cytotoxin From Phorbol Myristate Acetate-Treated Human Promyelocytes<xref ref-type="fn" rid="FN2">2</xref>. JNCI Journal of the National Cancer Institute. 73(1). 69–73. 14 indexed citations
10.
Flick, David A. & George E. Gifford. (1984). Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. Journal of Immunological Methods. 68(1-2). 167–175. 690 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026